Common diabetes drug tested to protect against radiation side effects in thyroid cancer
NCT ID NCT03109847
First seen Dec 18, 2025 · Last updated May 13, 2026 · Updated 17 times
Summary
This small pilot study looked at whether metformin, a common diabetes medicine, could reduce side effects like dry mouth and taste changes caused by radioactive iodine treatment in people with thyroid cancer. The study planned to enroll 13 participants but was terminated early. The goal was to see if metformin could protect healthy tissues from radiation damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.